788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827577936678486016 |
|---|---|
| author | Jeffrey Schlom Leisha A Emens Howard Kaufman James Hodge Sailaja Battula Kellsye Fabian Ginette Santiago-Sanchez |
| author_facet | Jeffrey Schlom Leisha A Emens Howard Kaufman James Hodge Sailaja Battula Kellsye Fabian Ginette Santiago-Sanchez |
| author_sort | Jeffrey Schlom |
| collection | DOAJ |
| first_indexed | 2024-03-08T21:33:54Z |
| format | Article |
| id | doaj.art-2f3bdd4b422f46a1b187d0fadbd145fe |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-08T21:33:54Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-2f3bdd4b422f46a1b187d0fadbd145fe2023-12-21T00:15:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0788788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer modelJeffrey Schlom0Leisha A Emens1Howard Kaufman2James Hodge3Sailaja Battula4Kellsye Fabian5Ginette Santiago-Sanchez61National Cancer Institute, National Institutes of Health, Bethesda3Ankyra Therapeutics, Pittsburgh, PA, USA4Ankyra Therapeutics/Massachusetts General Hospital, Boston, MA, USA1National Cancer Institute, National Institutes of Health, Bethesda2Ankyra Therapeutics, Boston, MA, USA1National Cancer Institute, National Institutes of Health, Bethesda1National Cancer Institute, National Institutes of Health, Bethesda |
| spellingShingle | Jeffrey Schlom Leisha A Emens Howard Kaufman James Hodge Sailaja Battula Kellsye Fabian Ginette Santiago-Sanchez 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model Journal for ImmunoTherapy of Cancer |
| title | 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model |
| title_full | 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model |
| title_fullStr | 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model |
| title_full_unstemmed | 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model |
| title_short | 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model |
| title_sort | 788 improved immunologic and therapeutic activity of anchored interleukin il 12 immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model |
| work_keys_str_mv | AT jeffreyschlom 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel AT leishaaemens 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel AT howardkaufman 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel AT jameshodge 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel AT sailajabattula 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel AT kellsyefabian 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel AT ginettesantiagosanchez 788improvedimmunologicandtherapeuticactivityofanchoredinterleukinil12immunotherapyincombinationwithcytotoxicchemotherapyandimmunecheckpointinhibitorinaheadandneckcancermodel |